NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
6.56
+0.87 (15.29%)
At close: Oct 7, 2026, 4:00 PM EDT
6.55
-0.01 (-0.23%)
After-hours: Oct 7, 2026, 7:30 PM EDT
NextCure Market Cap
NextCure has a market cap or net worth of $30.03 million as of October 7, 2026. That makes NextCure the 34,227th most valuable company in the world and 5,024th in the United States. Its market cap has increased by 87.01% in one year.
Market Cap
30.03M
Enterprise Value
14.61M
1-Year Change
87.01%
Global Rank
Country Rank
#5,024 United States
Category
ChartMarket Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $30.03M, a decrease of -93.12%. That is a compound annual growth rate of -30.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 30.03M | -39.64% |
| Dec 31, 2025 | 49.74M | 130.37% |
| Dec 31, 2024 | 21.59M | -32.12% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Actinium Pharmaceuticals | 33.64M |
| Aligos Therapeutics | 33.50M |
| TransCode Therapeutics | 29.80M |
| GridAI Technologies | 29.17M |
| IGC Pharma | 28.95M |
| Immutep | 28.88M |
| Context Therapeutics | 28.72M |
| Seres Therapeutics | 27.32M |